<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">15196216</PMID>
        <DateCompleted>
            <Year>2004</Year>
            <Month>08</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0019-2805</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>112</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2004</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Immunology</Title>
                <ISOAbbreviation>Immunology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>471-80</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>In view of the presence of a large number of epithelial cells in the alveoli of the lung and their ability to produce various cytokines and chemokines, the possible role of alveolar epithelial cells in the innate immune response to tuberculosis was examined. The human alveolar epithelial cell line A549 was used as a model. The ability of A549 cells to induce nitric oxide (NO) in response to Mycobacterium tuberculosis infection was taken as an in vitro correlate of innate immunity. M. tuberculosis infection induced A549 cells to produce significant levels of NO and to express inducible nitric oxide synthase mRNA at 48 hr of infection. However, the amount of NO released at this point was not mycobactericidal. Cytokine stimulation (interferon-gamma, tumour necrosis factor-alpha, interleukin-1beta, alone or in combination) of the infected A549 cells induced a higher concentration of NO. The study of colony-forming units (CFU) as a measure of the mycobactericidal capacity of A549 cells revealed a reduction in CFU of M. tuberculosis by 39.29% (from 10.62 +/- 0.48 - 6.392 +/- 0.54) following cytokine stimulation of the infected cells. Interestingly gamma-irradiated M. tuberculosis H37Rv could also induce higher than basal level of NO. Therefore we examined mycobacterial antigenic components for their possible role in NO production. We observed that A549 cells produced significantly higher amounts of NO at 48 hr when treated with mycobacterial whole cell lysates, cell wall or cell membrane preparations. The release of NO and the resultant mycobactericidal activity could be further enhanced by simultaneously conditioning the M. tuberculosis infected A549 cells with cytokine and mycobacterial components. These results suggest that alveolar epithelial cells respond to their microenvironment, which is constituted of various cytokines and macrophage-processed antigens and may contribute to the innate immune response to tuberculosis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Roy</LastName>
                    <ForeName>Sugata</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology, V. P. Chest Institute, University of Delhi, Delhi, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Sadhna</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aggarwal</LastName>
                    <ForeName>Ramesh</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bose</LastName>
                    <ForeName>Mridula</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Immunology</MedlineTA>
            <NlmUniqueID>0374672</NlmUniqueID>
            <ISSNLinking>0019-2805</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007375">Interleukin-1</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>31C4KY9ESH</RegistryNumber>
                <NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>82115-62-6</RegistryNumber>
                <NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="C496319">NOS2 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="D019001">Nitric Oxide Synthase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.13.39</RegistryNumber>
                <NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007375" MajorTopicYN="N">Interleukin-1</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019001" MajorTopicYN="N">Nitric Oxide Synthase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011650" MajorTopicYN="N">Pulmonary Alveoli</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2004</Year>
                <Month>6</Month>
                <Day>16</Day>
                <Hour>5</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2004</Year>
                <Month>8</Month>
                <Day>28</Day>
                <Hour>5</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2004</Year>
                <Month>6</Month>
                <Day>16</Day>
                <Hour>5</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">15196216</ArticleId>
            <ArticleId IdType="doi">10.1046/j.1365-2567.2004.01905.x</ArticleId>
            <ArticleId IdType="pii">IMM1905</ArticleId>
            <ArticleId IdType="pmc">PMC1782514</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1997 May 13;94(10):5243-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9144222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1996 Apr;64(4):1400-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8606107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Immunopathol Pharmacol. 1999 May-Aug;12(2):69-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12783649</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2000 Dec 23-30;356(9248):2133-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11191539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1988 Oct 1;141(7):2407-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3139757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lab Clin Med. 1995 Aug;126(2):108-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7636384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Today. 1994 Mar;15(3):100-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7909663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 1991 Sep 13;142(2):257-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1919029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10089-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7524082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1995 Dec 1;155(11):5343-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7594549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1996 Mar;64(3):683-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8641767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1990 Dec;86(6):1945-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2254454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 2002 Aug;70(8):4591-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12117972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 2000 Nov;68(11):6300-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11035739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2003 Dec 1;171(11):6052-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14634118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1999 Oct 1;163(7):3898-906</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10490990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tuber Lung Dis. 2000;80(4-5):173-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11052906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 1999 Oct 1;163(7):3936-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10490995</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunobiology. 1993 Nov;189(3-4):316-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8125515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1995 Dec;63(12):4802-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7591139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1996 Jul;64(7):2673-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8698494</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEMS Microbiol Lett. 2002 Jul 2;212(2):145-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12113926</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 1994 Aug 30;203(1):209-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7521161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nitric Oxide. 1999 Aug;3(4):348-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10444374</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tuber Lung Dis. 1997;78(5-6):247-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10209679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 2002 Sep;70(9):5322-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12183593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1997 Nov;176(5):1351-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9359738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1998 Aug 28;273(35):22201-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9712833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1997 Sep;65(9):3644-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9284131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 1998 Jul 30;248(3):871-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9704020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microb Pathog. 2003 Aug;35(2):49-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12901843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Lett. 1995 Nov;48(1):59-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8847093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anal Biochem. 1987 Apr;162(1):156-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2440339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Med. 1996 Mar;2(2):226-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8726465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1998 Mar;66(3):1121-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9488404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 1988 May;56(5):1232-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3128482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Immunol. 1991 Feb;3(1):65-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1711326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Dis. 1998 Oct;178(4):1105-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9806041</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
